Key statistics
On Monday, Pulmonx Corp (4NI:FRA) closed at 1.26, 13.51% above the 52 week low of 1.11 set on Nov 21, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.26 |
|---|---|
| High | 1.26 |
| Low | 1.26 |
| Bid | 1.29 |
| Offer | 1.30 |
| Previous close | 1.35 |
| Average volume | 1.00k |
|---|---|
| Shares outstanding | 41.25m |
| Free float | 36.81m |
| P/E (TTM) | -- |
| Market cap | 65.17m USD |
| EPS (TTM) | -1.41 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 07:39 GMT.
More ▼
Announcements
- Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
- Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Pulmonx Reports Third Quarter 2025 Financial Results
- Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025
- Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025
- Pulmonx to Participate in September Investor Conferences
- Pulmonx Reports Second Quarter 2025 Financial Results
- Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference
- Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025
- Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
More ▼
